News
MMSI
68.17
-2.73%
-1.91
Assessing Merit Medical Systems (MMSI) Valuation After Recent Share Price Weakness
Simply Wall St · 10h ago
Weekly Report: what happened at MMSI last week (0302-0306)?
Weekly Report · 3d ago
Merit Medical Systems Enters Oversold Territory (MMSI)
NASDAQ · 03/05 17:08
Merit Medical Earnings Call Highlights Profitable Growth
TipRanks · 03/03 00:24
Weekly Report: what happened at MMSI last week (0223-0227)?
Weekly Report · 03/02 10:07
Merit Medical’s Expansion Push Tests Acquisition Execution And Growth Targets
Simply Wall St · 02/28 22:36
Merit Medical Cut to Equal-Weight From Overweight by Wells Fargo
Dow Jones · 02/26 14:59
Merit Medical Price Target Cut to $78.00/Share From $95.00 by Wells Fargo
Dow Jones · 02/26 14:59
Wells Fargo Downgrades Merit Medical Systems to Equal-Weight, Lowers Price Target to $78
Benzinga · 02/26 14:49
Merit Medical Systems (MMSI) Premium P/E Faces Slower 6.8% EPS Growth Narrative Test
Simply Wall St · 02/26 12:20
MERIT MEDICAL SYSTEMS, INC. <MMSI.O>: WELLS FARGO CUTS TARGET PRICE TO $78 FROM $95
Reuters · 02/26 11:21
Wells Fargo downgrades Merit Medical on 2026 guidance uncertainty
TipRanks · 02/26 10:56
Merit Medical downgraded to Equal Weight from Overweight at Wells Fargo
TipRanks · 02/26 10:11
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite
Reuters · 02/26 07:31
Merit Medical Is Maintained at Outperform by Barrington Research
Dow Jones · 02/25 21:46
Merit Medical Price Target Raised to $109.00/Share From $106.00 by Barrington Research
Dow Jones · 02/25 21:46
Barrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $109
Benzinga · 02/25 21:35
Merit Medical price target lowered to $104 from $108 at Baird
TipRanks · 02/25 14:11
5 Analysts Have This To Say About Merit Medical Systems
Benzinga · 02/25 14:00
Merit Medical projects 6%-8% revenue growth for 2026 while divesting DualCap and strengthening global platforms
Seeking Alpha · 02/25 13:32
More
Webull provides a variety of real-time MMSI stock news. You can receive the latest news about Merit Med Sys Inc through multiple platforms. This information may help you make smarter investment decisions.
About MMSI
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.